Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Flanon Coulibaly"'
Autor:
Jie Liu, Christopher R Sudfeld, Per Ashorn, Queen Dube, Tahmeed Ahmed, Pratibha Dhingra, Usha Dhingra, Arup Dutta, Sunil Sazawal, Karim Manji, Rodrick Kisenge, Mohamed Bakari, Christopher P Duggan, Rajiv Bahl, Naor Bar-Zeev, Ayesha De Costa, Nigel Cunliffe, Sadia Shakoor, Desiree Witte, Doreen Rwigi, Judd L Walson, Shahida Qureshi, Eric Houpt, James Platts-mills, Jonathon Simon, Chifundo Ndamala, Sarah Somji, Abraham Samma, Fadima Cheick Haidara, Karen Kotloff, Emily L Deichsel, Md Chisti, Benson Singa, Patricia Pavlinac, Samba Sow, Mohammad Tahir Yousafzai, Farah Qamar, Muhammad Waliur Rahman, Irin Parvin, Md. Farhad Kabir, Anil Kumar Sharma, Vijay Kumar Jaiswal, Churchil Nyabinda, Christine McGrath, Maurine Anyango, Kevin Mwangi Kariuki, Stephanie N Tornberg-Belanger, Flanon Coulibaly, Jasnehta Permala-Booth, Dramane Malle, Latif Ndeketa, Rozina Thobani, Jan Mohammed, Cecylia Msemwa
Publikováno v:
BMJ Paediatrics Open, Vol 8, Iss 1 (2024)
Objective The objective was to assess the association between nutritional and clinical characteristics and quantitative PCR (qPCR)-diagnosis of bacterial diarrhoea in a multicentre cohort of children under 2 years of age with moderate to severe diarr
Externí odkaz:
https://doaj.org/article/851dbfb47d3840fb9d7ac9608dc4bedf
Autor:
Justin R. Ortiz, MD, Rachel S. Laufer, MPH, Steven M. Brunwasser, PhD, Flanon Coulibaly, MD, Fatoumata Diallo, MD, Moussa Doumbia, MD, Amanda J. Driscoll, PhD, Deshayne B. Fell, PhD, Fadima C. Haidara, MD, Tina V. Hartert, MD, Adama M. Keita, MD, Kathleen M. Neuzil, MD, Brittney M. Snyder, PhD, Samba Sow, MD, Meagan C. Fitzpatrick, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 2, Iss 2, Pp 100092- (2023)
Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI) in young children and is associated with subsequent recurrent wheezing illness and asthma (wheeze/asthma). RSV prevention may therefore reduc
Externí odkaz:
https://doaj.org/article/6f63f8b1c0734921b58c8013c96d2620
Autor:
Rachel S Laufer, Ranju Baral, Andrea G Buchwald, James D Campbell, Flanon Coulibaly, Fatoumata Diallo, Moussa Doumbia, Amanda J Driscoll, Alison P Galvani, Adama M Keita, Kathleen M Neuzil, Samba Sow, Clint Pecenka, Justin R Ortiz, Meagan C Fitzpatrick
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 5, p e0001432 (2023)
Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and ped
Externí odkaz:
https://doaj.org/article/be68965fcf674c6e8e4e1bc521d36f8a
Autor:
Andrea G. Buchwald PhD, Ibrahima Teguete MD, Moussa Doumbia MD, Fadima C. Haidara MD, Flanon Coulibaly MD, Fatoumata Diallo MD, Samba O. Sow MD, MSc, William C. Blackwelder PhD, Milagritos D. Tapia MD
Publikováno v:
Global Pediatric Health, Vol 6 (2019)
Preterm birth is a primary outcome of interest in maternal vaccination trials but determination of gestational age is challenging in limited-resource settings. This study compares the New Ballard Score and fundal height measurements with the current
Externí odkaz:
https://doaj.org/article/040b2e3f596641c19969e5446480679d
Autor:
Evan W Orenstein, Lauren A V Orenstein, Kounandji Diarra, Mahamane Djiteye, Diakaridia Sidibé, Fadima C Haidara, Moussa F Doumbia, Fatoumata Diallo, Flanon Coulibaly, Adama M Keita, Uma Onwuchekwa, Ibrahima Teguete, Milagritos D Tapia, Samba O Sow, Myron M Levine, Richard Rheingans
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171499 (2017)
BACKGROUND:Maternal influenza immunization has gained traction as a strategy to diminish maternal and neonatal mortality. However, efforts to vaccinate pregnant women against influenza in developing countries will require substantial investment. We p
Externí odkaz:
https://doaj.org/article/77cd0df1c29e403799434af11927d3bc
Autor:
Justin R. Ortiz, Samba O. Sow, Rachel S. Laufer, Andrea G. Buchwald, Alison P. Galvani, Clint Pecenka, Fadima Cheick Haidara, Lauren A.V. Orenstein, Flanon Coulibaly, Ranju Baral, Amanda J. Driscoll, James D. Campbell, Milagritos D. Tapia, Moussa Doumbia, Kathleen M. Neuzil, Karen L. Kotloff, Evan W. Orenstein, Adama Mamby Keita, Fatoumata Diallo, Meagan C. Fitzpatrick
Publikováno v:
Vaccine
Highlights • New RSV prevention products can substantially reduce disease burden. • Longer-acting monoclonal antibodies, priced affordably, are likely cost-effective. • Maternal vaccines meeting preferred product characteristics would be cost-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143cd0461c1a125ce4827d3407c1cd98
http://europepmc.org/articles/PMC8377743
http://europepmc.org/articles/PMC8377743
Autor:
Rachel S. Laufer, Ranju Baral, Andrea G. Buchwald, James D. Campbell, Flanon Coulibaly, Fatoumata Diallo, Moussa Doumbia, Amanda J. Driscoll, Alison P. Galvani, Adama M. Keita, Kathleen M. Neuzil, Samba Sow, Clint Pecenka, Justin R. Ortiz, Meagan C. Fitzpatrick
BackgroundRespiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785f696fa3d10a050bcb5079fcb5d9bd
https://doi.org/10.1101/2022.05.19.22275309
https://doi.org/10.1101/2022.05.19.22275309
Autor:
Saad B Omer, Dayna R Clark, Shabir A Madhi, Milagritos D Tapia, Marta C Nunes, Clare L Cutland, Eric A F Simões, Anushka R Aqil, Joanne Katz, James M Tielsch, Mark C Steinhoff, Niteen Wairagkar, William Blackwelder, Joseph Bresee, Flanon Coulibaly, Boubacar Diallo, Fatoumata Diallo, Wilbur Chen, Moussa Doumbia, Fadima Cheick Haidara, Adama Mamby Keita, Alexander Klimov, Mamoudou Kodio, Karen Kotloff, Myron M. Levine, Vladimir Mishcherkin, Uma Onwuchekwa, Sandra Panchalingam, Marcela Pasetti, Doh Sanogo, Samba Sow, Milagritos Tapia, Boubou Tamboura, Ibrahim Teguete, Sharon Tennant, Awa Traore, John Treanor, Janet A. Englund, Subarna K. Khatry, Jane Kuypers, Steven C. LeClerq, Luke C. Mullany, Laxman Shrestha, Mark C. Steinhoff, James M. Tielsch, Peter V. Adrian, Clare L. Cutland, Andrea Hugo, Stephanie Jones, Locadiah Kuwanda, Keith P. Klugman, Shabir A. Madhi, Kathleen M. Neuzil, Nadia van Niekerk, Marta C. Nunes, Justin R. Ortiz, Eric A.F. Simões, Florette Treurnicht, Marietjie Venter, Avy Violari, Adriana Weinberg
Publikováno v:
The Lancet. Respiratory Medicine
Summary Background Maternal influenza immunisation can reduce morbidity and mortality associated with influenza infection in pregnant women and young infants. We aimed to determine the vaccine efficacy of maternal influenza immunisation against mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c61ebec0368b9b87cdd3700fa0cd9c3
https://doi.org/10.1016/s2213-2600(19)30479-5
https://doi.org/10.1016/s2213-2600(19)30479-5
Autor:
Fatoumata Diallo, Awa Traore, D.A. Clark, Moussa Doumbia, Milagritos D. Tapia, Fadima Cheick Haidara, Flanon Coulibaly, Ray Borrow, Myron M. Levine, Samba O. Sow, Helen Findlow, Nicholas H Schluterman, Adama Mamby Keita
Publikováno v:
Vaccine
Highlights • Immunisation with MCV during pregnancy resulted in an antibody response. • Maternal immunization with MCV conveyed protective levels of MenA IgG at birth. • Infant antibody levels declined over the first 3 months of life.
A pr
A pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e019ab7b09ec0e7038687d340bcacf
http://europepmc.org/articles/PMC6990398
http://europepmc.org/articles/PMC6990398
Autor:
Karen L. Kotloff, Fatoumata Diallo, Awa Traore, Sharon M. Tennant, Ibrahima Téguété, Doh Sanogo, Julie Villanueva, Boubou Tamboura, Wilbur H. Chen, Moussa Doumbia, Samba O. Sow, Milagritos D. Tapia, Andrea G. Buchwald, Joseph S. Bresee, Flanon Coulibaly, Mamoudou Kodio, Ellen DeMatt, Lauren A.V. Orenstein, Nicholas H Schluterman, Myron M. Levine, William C. Blackwelder, Marcela F. Pasetti, Adama Mamby Keita, Evan W. Orenstein, Fadima Cheick Haidara, Uma Onwuchekwa, John J. Treanor
Publikováno v:
The Lancet. Infectious Diseases
Summary Background Despite the heightened risk of serious influenza during infancy, vaccination is not recommended in infants younger than 6 months. We aimed to assess the safety, immunogenicity, and efficacy of maternal immunisation with trivalent i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22b958a8ca2c527664ff910cf56e3cb4